Multiplexed Imaging Analysis of the Tumor-Immune Microenvironment Reveals Predictors of Outcome in Triple-Negative Breast Cancer
A. N. Patwa, R. Yamashita, J. Long, M. Angelo, L. Keren, D. Rubin
Abstract
Triple-negative breast cancer, the poorest-prognosis breast cancer subtype, lacks clinically approved biomarkers for patient risk stratification and treatment management. Prior literature has shown that interrogation of the tumor-immune microenvironment may be a promising approach for the discovery of methods to fill these gaps. Recently developed high-dimensional tissue imaging technology, such as multiplexed ion beam imaging, provide spatial context to protein expression in the microenvironment, allowing in-depth characterization of cellular processes. We demonstrate that profiling the functional proteins involved in cell-to-cell interactions in the microenvironment can predict recurrence and overall survival. We highlight the immunological relevance of the immunoregulatory proteins PD-1, PD-L1, IDO, and Lag3 by tying interactions involving them to recurrence and survival. Multivariate analysis reveals that our methods provide additional prognostic information compared to clinical variables. In this work, we present a computational pipeline for the examination of the tumor-immune microenvironment using multiplexed ion-beam imaging that produces interpretable results, and is generalizable to other cancer types.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prediction of Outcome from Spatial Protein Profiling of Triple-Negative Breast Cancers
Ali Foroughi pour, Te-Chia Wu, … Jeffrey H. Chuang·Communications MedicinePeer-reviewed·Jan 29, 2026
- Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer
Haoyang Mi, Ravi Varadhan, … Aleksander S. Popel·bioRxiv·Dec 18, 2023
- Robust biomarker discovery through multiplatform multiplex image analysis of breast cancer clinical cohorts
- Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition
Noah F. Greenwald, Iris Nederlof, … Michael Angelo·bioRxiv·Jan 26, 2025
- A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
- Single RNA molecule resolution spatial imaging of immunotherapy response in triple negative breast tumors harboring tertiary lymphoid structures
Richard H. Mebane, Teia Noel, … Simon Knott·bioRxiv·Mar 19, 2024